AI assistant
PARAGON CARE LIMITED — Call Transcript 2026
Feb 23, 2026
65551_rns_2026-02-23_f68e0139-229e-411c-9cd0-62cd5a9a0369.pdf
Call Transcript
Open in viewerOpens in your device viewer
24 February 2026
==> picture [125 x 159] intentionally omitted <==
ASX ANNOUNCEMENT
PARAGONCARE 2026 HALF-YEAR FINANCIAL RESULTS INVESTOR CONFERENCE CALL
Paragon Care Limited (ASX: PGC) (‘ParagonCare’ or ‘the Company’) advises its 1H FY26 Financial Results and Investor Presentation will be released to the ASX on 25 February 2026.
Following the release, Chief Executive Officer, Carmen Riley, and Chief Financial Officer, Brendon Pentland, will host an investor conference call and webcast including a Q&A session. Participants are encouraged to register before the start of the call using the details below.
Date: Wednesday, 25 February 2026
Time: 12:00pm (Australian Eastern Daylight Time)
Webcast Link:
The audio webcast and slide presentation registration will be accessible via the following link:
PGC 1H26 Results Conference Call
Please note that registered participants will receive their dial-in number upon registration.
---ENDS---
This release has been approved by the Board of Paragon Care Limited.
For further information, please contact:
Investors
Howard Marks Automic Group +61 402 438 019 [email protected]
About Paragon Care Limited
Paragon Care Limited (ASX:PGC) is an Australian based listed company in the healthcare sector. It is a leading provider of medical equipment, devices, consumables, pharmaceuticals, complementary medicines, nutritional supplies, and manufacturer of Blood Bank diagnostic reagents to the healthcare markets in Australia, New Zealand and Asia.